Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer
Clinical trial NCT05136326 · RECRUITING
Trial details
- NCT number
- NCT05136326
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-12-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.